Loading...

Australian Clinical Labs Limited

ACL.AXASX
HealthcareMedical - Diagnostics & Research
A$2.77
A$-0.01(-0.36%)

Australian Clinical Labs Limited (ACL.AX) Company Profile & Overview

Explore Australian Clinical Labs Limited’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Australian Clinical Labs Limited (ACL.AX) Company Profile & Overview

Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.

SectorHealthcare
IndustryMedical - Diagnostics & Research
CEOMs. Melinda McGrath

Contact Information

61 3 9538 6777
1868-1892 Dandenong Road, Clayton, VIC, 3168

Company Facts

4,900 Employees
IPO DateMay 14, 2021
CountryAU
Actively Trading

Frequently Asked Questions